About Ribbon Biolabs
Ribbon Biolabs is a company based in Vienna (Austria) founded in 2017 by Harold P. de Vladar. Ribbon Biolabs has raised $20.07 million across 4 funding rounds from investors including European Union, Austria Wirtschaftsservice and Hadean Ventures. Ribbon Biolabs offers products and services including Linear DNA and Plasmid DNA. Ribbon Biolabs operates in a competitive market with competitors including Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
- Headquarter Vienna, Austria
- Founders Harold P. de Vladar
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ribbon Bio Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.07 M (USD)
in 4 rounds
-
Latest Funding Round
$20.07 M (USD), Series A
Jan 31, 2022
-
Investors
European Union
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ribbon Biolabs
Ribbon Biolabs offers a comprehensive portfolio of products and services, including Linear DNA and Plasmid DNA.
Produces high-accuracy linear DNA up to 12 kb for biotech use.
Offers plasmid DNA up to 20 kb with complex parameters.
People of Ribbon Biolabs
Unlock access to complete
Funding Insights of Ribbon Biolabs
Ribbon Biolabs has successfully raised a total of $20.07M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $20.07 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $20.1M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series A - Ribbon Biolabs | Valuation | Hadean Ventures | |
| May, 2020 | Amount | Grant - Ribbon Biolabs | Valuation |
investors |
|
| Dec, 2019 | Amount | Grant - Ribbon Biolabs | Valuation |
investors |
Investors in Ribbon Biolabs
Ribbon Biolabs has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Austria Wirtschaftsservice and Hadean Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Innovative technologies and startups are supported with capital and expertise.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ribbon Biolabs
Financial Statements - Ribbon Biolabs
Ribbon Biolabs Comparisons
Competitors of Ribbon Biolabs
Ribbon Biolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Provider of integrated suite for advanced genetic design and manufacturing
|
Latest news on Ribbon Biolabs
Frequently Asked Questions about Ribbon Biolabs
Ribbon Biolabs was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Ribbon Biolabs is headquartered in Vienna, Austria.
Harold P. de Vladar is the current CEO of Ribbon Biolabs. They have also founded this company.
Ribbon Biolabs is a funded company, having raised a total of $20.07M across 4 funding rounds to date. The company's 1st funding round was a Grant of $55.1K, raised on Mar 08, 2019.
Ribbon Biolabs was founded in 2017 in Vienna, Austria, within the biotechnology sector. A platform for high-throughput DNA synthesis is developed, enabling the creation of libraries up to thousands of base pairs in length. Genomes are constructed, along with DNA-based products for data storage, computing applications, and nanotechnological devices. Operations emphasize genetic solutions for advanced biological engineering.
Ribbon Biolabs offers Linear DNA and Plasmid DNA.
Ribbon Biolabs has 8 investors. Key investors include European Union, Austria Wirtschaftsservice, Hadean Ventures, Lansdowne Partners, and Helicase Venture.